InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Knutson Gregory, Director. Director active across 1 company, notably U.S. Stem Cell, Inc.. Cumulatively, 3 disclosures have been logged. History available since 1 April 2020. The latest transaction was disclosed on 25 April 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Knutson Gregory is a Director at U.S. Stem Cell, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biotechnology sector allows him to provide valuable strategic insights. Gregory is committed to supporting the company's mission and fostering its growth.